Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance.
- NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_assertion description "[Purified protein derivative (PPD) skin tests often yield poor specificity, so that to develop new serological antigens for distinguishing between Mycobacterium tuberculosis infection and Bacille Calmette-Guerin (BCG) vaccination is a priority, especially for developing countries like China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance.
- NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_assertion evidence source_evidence_literature NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance.
- NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_assertion SIO_000772 19944383 NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance.
- NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_assertion wasDerivedFrom befree-20140225 NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance.
- NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_assertion wasGeneratedBy ECO_0000203 NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP266608.RAW_GJOpL-lZ1S1QcG1_2zAQW116H-Udtqnh6cEnAy6rc130_provenance.